Shandong Sinobioway Biomedicine Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 187.26 million compared to CNY 223.68 million a year ago. Revenue was CNY 187.64 million compared to CNY 224.32 million a year ago.

Net income was CNY 23.96 million compared to CNY 137.92 million a year ago. Basic earnings per share from continuing operations was CNY 0.0363 compared to CNY 0.2091 a year ago. Diluted earnings per share from continuing operations was CNY 0.0363 compared to CNY 0.2091 a year ago.